Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Other hematologic neoplasm 1Myeloid 1Lymphoid 1Classical hematology 1

Conditions

Precursor Cell Lymphoblastic Leukemia-Lymphoma 413Leukemia 346Leukemia, Myeloid, Acute 289Leukemia, Lymphocytic, Chronic, B-Cell 286Lymphoma 217Myelodysplastic Syndromes 207Lymphoma, Non-Hodgkin 196Burkitt Lymphoma 160Lymphoma, Follicular 149Lymphoma, Mantle-Cell 136Lymphoma, Large B-Cell, Diffuse 135Hodgkin Disease 131Multiple Myeloma 120Lymphoma, B-Cell, Marginal Zone 118Lymphoma, Large-Cell, Immunoblastic 95Leukemia, Myelogenous, Chronic, BCR-ABL Positive 91Hematologic Neoplasms 87Myeloproliferative Disorders 85Leukemia, Myeloid, Chronic-Phase 83Leukemia, Myeloid, Accelerated Phase 80Leukemia, Myelomonocytic, Chronic 78Recurrence 72Congenital Abnormalities 68Blast Crisis 64Precursor T-Cell Lymphoblastic Leukemia-Lymphoma 63Graft vs Host Disease 62Neoplasms, Plasma Cell 61Anemia, Refractory, with Excess of Blasts 60Primary Myelofibrosis 59Dendritic Cell Sarcoma, Interdigitating 59

Interventions

fludarabine phosphate 1Whole-Body Irradiation 1Thiotepa 1Melphalan 1Cyclophosphamide 1Clinical Trials, Phase I as Topic 1Busulfan 1Antilymphocyte Serum 1Alemtuzumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Metabolism, Inborn Errors × Cyclophosphamide × Other hematologic neoplasm × Clear all
NCT01049854 2018-08-21

CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant

New York Medical College

Phase 2 Completed
20 enrolled
Classical hematologyLymphoidMyeloidOther hematologic neoplasm

Bone Marrow Failure Disorders, Anemia, Sickle Cell, Immunologic Deficiency Syndromes, Leukemia, Lymphoma, Metabolism, Inborn Errors, Histiocytosis, beta-Thalassemia

Data powered by HemOnc (CC BY 4.0) Colophon âš¡